Abstract
This prospective observational study was conducted on 242 patients with clomiphene citrate (CC) resistant polycystic ovary syndrome (PCOS) who were allocated into two regimens of induction of ovulation, the first group(n=128) received both CC and tamoxifen and the second (n=114) received letrozole. The ovulation rate, endometrial thickness, number of dominant follicles, pregnancy rate, miscarriage rate and live birth rate were found comparable between the two groups. Combined therapy with CC and tamoxifen is beneficial in patients with PCOS who failed to respond to CC alone.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
